CELLSIGHT TECHNOLOGIES, INC.
Medtech · Private
PET imaging agent ([18F]F-AraG) for detecting T cell activity in Alzheimer's disease patients
- Grants
- $2.9M
- 3 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- $2.8M
- 5 awards · Health and Human S
- #179 of 4531 in medtech
- Patents
- 9
- 0 granted · 9 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201020122014201620182020202220242026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal contract | Department of Health and Human Services · TAS::75 0849::TAS SBIR Topic 307 Phase I Novel Imaging Agents To Expand The Clinical Toolkit For Cancer Diagnosis, Staging, And | $247,568 | |
| Federal contract | Department of Health and Human Services · Igf::ot::igf Further Determine Mechanism Of [18F] F-arag Accumulation In Various Types Of Immune Cells And Demonstrate Imaging Of Activated T Cells In Mice Undergoing Immunotherapies. | $15 | |
| Federal grant | Department of Health and Human Services · Phase II · Monitoring immune response to immunotherapies in cancer patients with VisAcT PET tracer | $1,020,143 | |
| Federal grant | Department of Health and Human Services · Phase II · Monitoring immune response to immunotherapies in cancer patients with VisAcT PET tracer | $1,020,835 | |
| Federal contract | Department of Health and Human Services · Igf::ot::igf SBIR Topic 376: A Noninvasive Pet Imaging Strategy For Longitudinal Monitoring Of Immune Contexture In The Tumor Microenvironment. Moonshot. | $299,641 | |
| Federal contract | Department of Health and Human Services · SBIR Phase I Topic 396 Evaluation Of [18F]F-ARAG, A T Cell-specific Pet Agent, As An Imaging Biomarker Predictive Of Response To Immunotherapies - Moonshot | $300,000 | |
| Federal contract | Department of Health and Human Services · SBIR Phase II - Topic 396 - Imaging For Cancer Immunotherapies | $1,995,174 | |
| Federal grant | Department of Health and Human Services · Phase II · Imaging intracerebral and systemic T cell immunity in patients with Alzheimer's disease using 18F-F-AraG | $871,261 |
Federal grant · SBIR/STTRFederal contract · USAspending
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 176 | CARINA MEDICAL LLC | $2.9M | — |
| 177 | PINMED, INC. | $2.9M | — |
| 178 | COLUMBUS NANOWORKS, INC. | $2.8M | — |
| 179 | CELLSIGHT TECHNOLOGIES, INC. | $2.8M | — |
| 180 | MAXQ RESEARCH LLC | $2.8M | — |
| 181 | SIBTECH, INC. | $2.8M | — |
| 182 | NVIGEN | $2.7M | $1.1M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Methods And Materials For Making Pet Radiotracersapplication
- Methods And Materials For Imaging Adipose Tissueapplication
- Methods And Materials For Using [18F]-F-ARAG In Cardiac Imagingapplication
- Methods And Materials For Making Pet Radiotracersapplication
- Methods And Materials For Imaging Adipose Tissueapplication
- Assessment Of Systemic Immunity Using [F18]F-ARA-G In Positron Emission Tomographyapplication
- Methods And Materials For Making Pet Radiotracersapplication
- METHODS AND MATERIALS FOR USING [ 18F]-F-AraG IN CARDIAC IMAGINGapplication
- ASSESSMENT OF SYSTEMIC IMMUNITY USING [F18]F-Ara-G IN POSITRON EMISSION TOMOGRAPHYapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.